137 related articles for article (PubMed ID: 16906509)
21. Site of oncologic specialty care for older adolescents in Utah.
Albritton KH; Wiggins CH; Nelson HE; Weeks JC
J Clin Oncol; 2007 Oct; 25(29):4616-21. PubMed ID: 17925557
[TBL] [Abstract][Full Text] [Related]
22. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.
Fern LA; Lewandowski JA; Coxon KM; Whelan J;
Lancet Oncol; 2014 Jul; 15(8):e341-50. PubMed ID: 24988937
[TBL] [Abstract][Full Text] [Related]
23. Registration and classification of adolescent and young adult cancer cases.
Pollock BH; Birch JM
Pediatr Blood Cancer; 2008 May; 50(5 Suppl):1090-3. PubMed ID: 18360832
[TBL] [Abstract][Full Text] [Related]
24. Adolescent under enrollment in national clinical research: it is time to ask why.
Rogers AS
J Adolesc Health; 1997 Dec; 21(6):374-5. PubMed ID: 9401855
[No Abstract] [Full Text] [Related]
25. The cohort of long-term survivors at the German childhood cancer registry.
Debling D; Spix C; Blettner M; Michaelis J; Kaatsch P
Klin Padiatr; 2008; 220(6):371-7. PubMed ID: 18949673
[TBL] [Abstract][Full Text] [Related]
26. Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer center.
Legge F; Eaton D; Molife R; Ferrandina G; Judson I; de Bono J; Kaye S
Gynecol Oncol; 2007 Mar; 104(3):551-6. PubMed ID: 17064758
[TBL] [Abstract][Full Text] [Related]
27. Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.
Joseph G; Dohan D
Cancer; 2009 Feb; 115(3):608-15. PubMed ID: 19127544
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of patient-reported outcomes in cancer clinical trials.
Gotay CC; Kawamoto CT; Bottomley A; Efficace F
J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
[TBL] [Abstract][Full Text] [Related]
29. Access to care.
Albritton KH; Eden T
Pediatr Blood Cancer; 2008 May; 50(5 Suppl):1094-8. PubMed ID: 18360836
[TBL] [Abstract][Full Text] [Related]
30. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
31. Selected Proceedings of the NICHD/FDA newborn drug development initiative: Part II.
Giacoia GP; Mattison DR
Clin Ther; 2006 Sep; 28(9):1337-41. PubMed ID: 17062307
[TBL] [Abstract][Full Text] [Related]
32. Improving enrollment in clinical trials for adolescents with cancer.
Shaw PH; Hayes-Lattin B; Johnson R; Bleyer A
Pediatrics; 2014 Jun; 133 Suppl 3():S109-13. PubMed ID: 24918208
[TBL] [Abstract][Full Text] [Related]
33. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
[TBL] [Abstract][Full Text] [Related]
34. The advance directive prevalence in long-term care: a comparison of relationships between a nurse practitioner healthcare model and a traditional healthcare model.
Lawrence JF
J Am Acad Nurse Pract; 2009 Mar; 21(3):179-85. PubMed ID: 19302695
[TBL] [Abstract][Full Text] [Related]
35. Increasing participation of women in early phase clinical trials approved by the FDA.
Pinnow E; Sharma P; Parekh A; Gevorkian N; Uhl K
Womens Health Issues; 2009; 19(2):89-93. PubMed ID: 19272558
[TBL] [Abstract][Full Text] [Related]
36. Relative lack of conditional survival improvement in young adults with cancer.
Bleyer A; Choi M; Fuller CD; Thomas CR; Wang SJ
Semin Oncol; 2009 Oct; 36(5):460-7. PubMed ID: 19835741
[TBL] [Abstract][Full Text] [Related]
37. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
38. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
Dilts DM; Sandler AB
J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
[TBL] [Abstract][Full Text] [Related]
39. Adolescent and young adult (AYA) oncology: the first A.
Bleyer A
Pediatr Hematol Oncol; 2007; 24(5):325-36. PubMed ID: 17613877
[TBL] [Abstract][Full Text] [Related]
40. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
